タクシーフォリン:增加水溶性和生物利用性的方法
Mark B Plotnikov1,2, Anna M Anishchenko1,3
1Department of Pharmacology, Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center, Russian Academy of Sciences, 3 Lenin ave., Tomsk, 634028, Russia.
Current pharmaceutical biotechnology
|August 13, 2025
概括
带有治疗潜力的黄类药物塔克西福林 (TAX) 面临生物可用性挑战,原因是溶解度差. 本综述探讨了技术,特别是纳米技术,以提高TAX的溶解性和改善药物开发.
科学领域:
- 药理学 药理学是指药理学的学科.
- 药物运输 药物运输 药物运输
- 黄类化合物化学 黄类化合物化学
背景情况:
- 塔克西福林 (TAX) 是一种二甲,是一种具有显著药理作用和商业兴趣的黄类药物.
- 它的治疗应用受阻于其不良的物理化学特性和不利的药理动力学,包括吸收,分布,新陈代谢和分泌.
- 提高TAX的溶解度对于提高其生物可用性和临床效用至关重要.
研究的目的:
- 审查改善Taxifolin (TAX) 溶解度和生物可用性的技术方法.
- 为了突出税收交付各种配方策略的有效性.
主要方法:
- 微化的微化.
- 晶体工程 晶体工程
- 自行微乳化系统 自行微乳化系统
- 脂质体和修饰的变化
- 微乳化系统是微乳化系统.
- 脂纳米粒子是一种脂纳米粒子.
- 包容性复合体 (克拉特酸盐生成)
- 化学修饰是一种化学修饰.
主要成果:
- 一些技术方法已经在提高TAX的溶解性和生物利用性方面取得了成功.
- 基于纳米技术的方法,包括脂质体和纳米颗粒,特别有效.
- 这些先进的配方显著提高了TAX的输送和治疗潜力.
结论:
- 技术干预,特别是纳米技术,为克服TAX可溶性和生物可用性限制提供了有希望的解决方案.
- 开发具有增强性质的新型TAX配方是创造创新治疗剂的关键.
- 改善TAX生物可用性为新药开发和扩展医疗应用铺平了道路.
相关概念视频
01:20Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
263
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
263
01:22Factors Influencing Drug Absorption: Physicochemical Parameters
435
The physicochemical characteristics of drugs play a crucial role in formulating stable and bioavailable drug products. The solubility of a drug, governed by the varying pH along the GI tract and its dissociation constant (pKa), is pivotal in determining its ionization state and absorption rate. Notably, weak acids and bases remain unionized and are absorbed more rapidly.
Enhanced drug absorption can be achieved by reducing particle sizes and increasing surface areas, thereby facilitating...
Enhanced drug absorption can be achieved by reducing particle sizes and increasing surface areas, thereby facilitating...
435
01:23Factors Influencing Bioavailability: First-Pass Elimination
7.0K
When a drug is taken orally, it undergoes a journey starting from the gastrointestinal (GI) tract, passing through the portal vein, reaching the liver, and finally entering the systemic circulation. This process involves the absorption of the drug across the GI tract. The liver is the primary site for metabolizing the drug, with some metabolism also occurring in the gut wall. This journey significantly reduces the quantity of the drug that reaches the systemic circulation, a phenomenon known as...
7.0K
01:27Factors Influencing Drug Absorption: Drug Dissolution
705
The pharmacokinetic journey of drugs from solid oral dosage forms into systemic circulation is multifaceted. It begins with disintegration, a prerequisite ensuring a solid dosage form's subdivision into minute particles. Dissolution occurs next as these granulated entities solubilize in gastrointestinal fluids. This solubilization is crucial for the succeeding stage, permeation, which describes the traversal of the drug across the intestinal membrane and its subsequent entry into the blood...
705
01:21Factors Affecting Dissolution: Drug pKa, Lipophilicity and GI pH
2.0K
Drug absorption within the gastrointestinal (GI) tract is a complex process influenced by several critical factors, including the site pH, the drug's dissociation constant (pKa), and the drug's lipophilicity. The GI tract exhibits a pH gradient, with an acidic environment in the stomach and a more alkaline environment in the small intestine. This pH variation directly affects the ionization state of drugs.
A drug's pKa and the pH of the gastrointestinal (GI) tract play crucial roles...
A drug's pKa and the pH of the gastrointestinal (GI) tract play crucial roles...
2.0K
01:23Factors Affecting Dissolution: Particle Size and Effective Surface Area
1.0K
Dissolution kinetics, an essential aspect of oral drug delivery, is significantly influenced by the drug's particle size. According to the Noyes-Whitney dissolution model, the dissolution rate correlates directly with the drug's surface area. The larger the surface area, the higher the drug's solubility in water, leading to a faster drug dissolution rate. Reducing particle size increases the effective surface area, enhancing the dissolution process. Micronization and nanosizing are...
1.0K